Bhekisisa, via Daily Maverick, has produced an informative article discussing significant drug interactions between lenacapavir (LEN) and enzyme-inducing TB treatment such as rifampicin, rifabutin and rifapentine.

A study by Vogeley and colleagues explored the prevalence of poor health literacy and self-management of health in patients aged 45-64. Up to two thirds of midlife adults in the USA live with at least one chronic health condition.

We previously highlighted a case report of pyridoxine toxicity from nutritional supplement use in January 2025.